APO Research
Talk to an analyst

APO RESEARCH · REPORT

Short-acting Nicotine Replacement

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Short-acting Nicotine Replacement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 June 2026190 pages

Choose your research edition.

Industry ResearchShort-acting Nicotine Replacement Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Short-acting Nicotine Replacement Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Short-acting Nicotine Replacement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Short-acting Nicotine Replacement Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Short-acting Nicotine Replacement Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Short-acting Nicotine Replacement market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Short-acting Nicotine Replacement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Short-acting Nicotine Replacement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Short-acting Nicotine Replacement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Short-acting Nicotine Replacement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Short-acting Nicotine Replacement include Nicorette (Johnson & Johnson), Nicotinell (Haleon), Equate (Walmart), Thrive (Haleon), NiQuitin (Perrigo), Philip Morris, Alkalon, LUCY GOODS and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Short-acting Nicotine Replacement market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Short-acting Nicotine Replacement and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Short-acting Nicotine Replacement sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Short-acting Nicotine Replacement market size, projected growth trends, production technologies, key applications, and end-use industries.

Short-acting Nicotine Replacement Segment by Company

Nicorette (Johnson & Johnson)

Nicotinell (Haleon)

Equate (Walmart)

Thrive (Haleon)

NiQuitin (Perrigo)

Philip Morris

Alkalon

LUCY GOODS

Dr. Reddy's Laboratories

Nicotex (Cipla Health)

Swedish Match

Altria

British American Tobacco (BAT)

Skruf Snus

Japan Tobacco International (JTI)

Short-acting Nicotine Replacement Segment by Type

Nicotine Gum

Nicotine Lozenge

Nasal Spray

Oral Inhaler

Nicotine Pouches

Short-acting Nicotine Replacement Segment by Application

Online Sales

Offline Sales

Short-acting Nicotine Replacement Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short-acting Nicotine Replacement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Short-acting Nicotine Replacement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short-acting Nicotine Replacement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Short-acting Nicotine Replacement market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Short-acting Nicotine Replacement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Short-acting Nicotine Replacement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Short-acting Nicotine Replacement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Short-acting Nicotine Replacement Industry Trends Table 2. Short-acting Nicotine Replacement Industry Drivers Table 3. Short-acting Nicotine Replacement Industry Opportunities and Challenges Table 4. Short-acting Nicotine Replacement Industry Restraints Table 5. Global Short-acting Nicotine Replacement Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Short-acting Nicotine Replacement Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Short-acting Nicotine Replacement Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Short-acting Nicotine Replacement Sales Market Share by Manufacturers Table 9. Global Short-acting Nicotine Replacement Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Short-acting Nicotine Replacement Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Short-acting Nicotine Replacement Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Short-acting Nicotine Replacement Manufacturers, Product Type & Application Table 13. Global Short-acting Nicotine Replacement Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Short-acting Nicotine Replacement by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Nicotine Gum Table 17. Major Manufacturers of Nicotine Lozenge Table 18. Major Manufacturers of Nasal Spray Table 19. Major Manufacturers of Oral Inhaler Table 20. Major Manufacturers of Nicotine Pouches Table 21. Global Short-acting Nicotine Replacement Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Short-acting Nicotine Replacement Sales by Type (2021-2026) & (k units) Table 23. Global Short-acting Nicotine Replacement Sales by Type (2027-2032) & (k units) Table 24. Global Short-acting Nicotine Replacement Sales Market Share by Type (2021-2026) Table 25. Global Short-acting Nicotine Replacement Sales Market Share by Type (2027-2032) Table 26. Global Short-acting Nicotine Replacement Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Short-acting Nicotine Replacement Revenue by Type (2021-2026) & (k units) Table 28. Global Short-acting Nicotine Replacement Revenue by Type (2027-2032) & (k units) Table 29. Global Short-acting Nicotine Replacement Revenue Market Share by Type (2021-2026) Table 30. Global Short-acting Nicotine Replacement Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Online Sales Table 32. Major Manufacturers of Offline Sales Table 33. Global Short-acting Nicotine Replacement Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Short-acting Nicotine Replacement Sales by Application (2021-2026) & (k units) Table 35. Global Short-acting Nicotine Replacement Sales by Application (2027-2032) & (k units) Table 36. Global Short-acting Nicotine Replacement Sales Market Share by Application (2021-2026) Table 37. Global Short-acting Nicotine Replacement Sales Market Share by Application (2027-2032) Table 38. Global Short-acting Nicotine Replacement Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Short-acting Nicotine Replacement Revenue by Application (2021-2026) & (k units) Table 40. Global Short-acting Nicotine Replacement Revenue by Application (2027-2032) & (k units) Table 41. Global Short-acting Nicotine Replacement Revenue Market Share by Application (2021-2026) Table 42. Global Short-acting Nicotine Replacement Revenue Market Share by Application (2027-2032) Table 43. Global Short-acting Nicotine Replacement Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Short-acting Nicotine Replacement Sales by Region (2021-2026) & (k units) Table 45. Global Short-acting Nicotine Replacement Sales Market Share by Region (2021-2026) Table 46. Global Short-acting Nicotine Replacement Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Short-acting Nicotine Replacement Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Short-acting Nicotine Replacement Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Short-acting Nicotine Replacement Sales by Country (2021-2026) & (k units) Table 50. North America Short-acting Nicotine Replacement Sales by Country (2027-2032) & (k units) Table 51. Europe Short-acting Nicotine Replacement Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Short-acting Nicotine Replacement Sales by Country (2021-2026) & (k units) Table 53. Europe Short-acting Nicotine Replacement Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Short-acting Nicotine Replacement Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Short-acting Nicotine Replacement Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Short-acting Nicotine Replacement Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Short-acting Nicotine Replacement Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Short-acting Nicotine Replacement Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Short-acting Nicotine Replacement Sales by Country (2027-2032) & (k units) Table 60. Global Short-acting Nicotine Replacement Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Short-acting Nicotine Replacement Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Short-acting Nicotine Replacement Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Short-acting Nicotine Replacement Revenue Market Share by Region (2021-2026) Table 64. Global Short-acting Nicotine Replacement Revenue Market Share by Region (2027-2032) Table 65. Nicorette (Johnson & Johnson) Company Information Table 66. Nicorette (Johnson & Johnson) Business Overview Table 67. Nicorette (Johnson & Johnson) Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Nicorette (Johnson & Johnson) Short-acting Nicotine Replacement Product Portfolio Table 69. Nicorette (Johnson & Johnson) Recent Development Table 70. Nicotinell (Haleon) Company Information Table 71. Nicotinell (Haleon) Business Overview Table 72. Nicotinell (Haleon) Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Nicotinell (Haleon) Short-acting Nicotine Replacement Product Portfolio Table 74. Nicotinell (Haleon) Recent Development Table 75. Equate (Walmart) Company Information Table 76. Equate (Walmart) Business Overview Table 77. Equate (Walmart) Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Equate (Walmart) Short-acting Nicotine Replacement Product Portfolio Table 79. Equate (Walmart) Recent Development Table 80. Thrive (Haleon) Company Information Table 81. Thrive (Haleon) Business Overview Table 82. Thrive (Haleon) Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Thrive (Haleon) Short-acting Nicotine Replacement Product Portfolio Table 84. Thrive (Haleon) Recent Development Table 85. NiQuitin (Perrigo) Company Information Table 86. NiQuitin (Perrigo) Business Overview Table 87. NiQuitin (Perrigo) Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. NiQuitin (Perrigo) Short-acting Nicotine Replacement Product Portfolio Table 89. NiQuitin (Perrigo) Recent Development Table 90. Philip Morris Company Information Table 91. Philip Morris Business Overview Table 92. Philip Morris Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Philip Morris Short-acting Nicotine Replacement Product Portfolio Table 94. Philip Morris Recent Development Table 95. Alkalon Company Information Table 96. Alkalon Business Overview Table 97. Alkalon Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Alkalon Short-acting Nicotine Replacement Product Portfolio Table 99. Alkalon Recent Development Table 100. LUCY GOODS Company Information Table 101. LUCY GOODS Business Overview Table 102. LUCY GOODS Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. LUCY GOODS Short-acting Nicotine Replacement Product Portfolio Table 104. LUCY GOODS Recent Development Table 105. Dr. Reddy's Laboratories Company Information Table 106. Dr. Reddy's Laboratories Business Overview Table 107. Dr. Reddy's Laboratories Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Dr. Reddy's Laboratories Short-acting Nicotine Replacement Product Portfolio Table 109. Dr. Reddy's Laboratories Recent Development Table 110. Nicotex (Cipla Health) Company Information Table 111. Nicotex (Cipla Health) Business Overview Table 112. Nicotex (Cipla Health) Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Nicotex (Cipla Health) Short-acting Nicotine Replacement Product Portfolio Table 114. Nicotex (Cipla Health) Recent Development Table 115. Swedish Match Company Information Table 116. Swedish Match Business Overview Table 117. Swedish Match Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Swedish Match Short-acting Nicotine Replacement Product Portfolio Table 119. Swedish Match Recent Development Table 120. Altria Company Information Table 121. Altria Business Overview Table 122. Altria Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Altria Short-acting Nicotine Replacement Product Portfolio Table 124. Altria Recent Development Table 125. British American Tobacco (BAT) Company Information Table 126. British American Tobacco (BAT) Business Overview Table 127. British American Tobacco (BAT) Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. British American Tobacco (BAT) Short-acting Nicotine Replacement Product Portfolio Table 129. British American Tobacco (BAT) Recent Development Table 130. Skruf Snus Company Information Table 131. Skruf Snus Business Overview Table 132. Skruf Snus Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Skruf Snus Short-acting Nicotine Replacement Product Portfolio Table 134. Skruf Snus Recent Development Table 135. Japan Tobacco International (JTI) Company Information Table 136. Japan Tobacco International (JTI) Business Overview Table 137. Japan Tobacco International (JTI) Short-acting Nicotine Replacement Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Japan Tobacco International (JTI) Short-acting Nicotine Replacement Product Portfolio Table 139. Japan Tobacco International (JTI) Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Short-acting Nicotine Replacement Distributors List Table 143. Short-acting Nicotine Replacement Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Short-acting Nicotine Replacement Product Image Figure 2. Global Short-acting Nicotine Replacement Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Short-acting Nicotine Replacement Market Size (2021-2032) & (US$ Million) Figure 4. Global Short-acting Nicotine Replacement Sales (2021-2032) & (k units) Figure 5. Global Short-acting Nicotine Replacement Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Short-acting Nicotine Replacement Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Nicotine Gum Image Figure 9. Nicotine Lozenge Image Figure 10. Nasal Spray Image Figure 11. Oral Inhaler Image Figure 12. Nicotine Pouches Image Figure 13. Global Short-acting Nicotine Replacement Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Short-acting Nicotine Replacement Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Short-acting Nicotine Replacement Sales Market Share by Type (2021-2032) Figure 16. Global Short-acting Nicotine Replacement Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Short-acting Nicotine Replacement Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Short-acting Nicotine Replacement Revenue Market Share by Type (2021-2032) Figure 19. Online Sales Image Figure 20. Offline Sales Image Figure 21. Global Short-acting Nicotine Replacement Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Short-acting Nicotine Replacement Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Short-acting Nicotine Replacement Sales Market Share by Application (2021-2032) Figure 24. Global Short-acting Nicotine Replacement Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Short-acting Nicotine Replacement Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Short-acting Nicotine Replacement Revenue Market Share by Application (2021-2032) Figure 27. North America Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Short-acting Nicotine Replacement Sales Market Share by Country (2021-2032) Figure 29. U.S. Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Short-acting Nicotine Replacement Sales Market Share by Country (2021-2032) Figure 34. Germany Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Short-acting Nicotine Replacement Sales Market Share by Country (2021-2032) Figure 41. China Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Short-acting Nicotine Replacement Sales Market Share by Country (2021-2032) Figure 49. Brazil Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Short-acting Nicotine Replacement Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Short-acting Nicotine Replacement Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Short-acting Nicotine Replacement Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Short-acting Nicotine Replacement Revenue (2021-2032) & (US$ Million) Figure 60. North America Short-acting Nicotine Replacement Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Short-acting Nicotine Replacement Revenue (2021-2032) & (US$ Million) Figure 62. Europe Short-acting Nicotine Replacement Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Short-acting Nicotine Replacement Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Short-acting Nicotine Replacement Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Short-acting Nicotine Replacement Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Short-acting Nicotine Replacement Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Short-acting Nicotine Replacement Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Short-acting Nicotine Replacement Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Nicotine Gum
  • Nicotine Lozenge
  • Nasal Spray
  • Oral Inhaler
  • Nicotine Pouches
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Nicorette (Johnson & Johnson)
  • Nicotinell (Haleon)
  • Equate (Walmart)
  • Thrive (Haleon)
  • NiQuitin (Perrigo)
  • Philip Morris
  • Alkalon
  • LUCY GOODS
  • Dr. Reddy's Laboratories
  • Nicotex (Cipla Health)
  • Swedish Match
  • Altria
  • British American Tobacco (BAT)
  • Skruf Snus
  • Japan Tobacco International (JTI)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Short-acting Nicotine Replacement Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Short-acting Nicotine Replacement Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Short-acting Nicotine Replacement Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Short-acting Nicotine Replacement Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Short-acting Nicotine Replacement Market Dynamics
  1. 2.1 Short-acting Nicotine Replacement Industry Trends
  2. 2.2 Short-acting Nicotine Replacement Industry Drivers
  3. 2.3 Short-acting Nicotine Replacement Industry Opportunities and Challenges
  4. 2.4 Short-acting Nicotine Replacement Industry Restraints
3 Short-acting Nicotine Replacement Market by Manufacturers
  1. 3.1 Global Short-acting Nicotine Replacement Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Short-acting Nicotine Replacement Sales by Manufacturers (2021-2026)
  3. 3.3 Global Short-acting Nicotine Replacement Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Short-acting Nicotine Replacement Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Short-acting Nicotine Replacement Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Short-acting Nicotine Replacement Manufacturers, Product Type & Application
  7. 3.7 Global Short-acting Nicotine Replacement Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Short-acting Nicotine Replacement Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Short-acting Nicotine Replacement Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Short-acting Nicotine Replacement Tier 1, Tier 2, and Tier 3
4 Short-acting Nicotine Replacement Market by Type
  1. 4.1 Short-acting Nicotine Replacement Type Introduction
  2. 4.1.1 Nicotine Gum
  3. 4.1.2 Nicotine Lozenge
  4. 4.1.3 Nasal Spray
  5. 4.1.4 Oral Inhaler
  6. 4.1.5 Nicotine Pouches
  7. 4.2 Global Short-acting Nicotine Replacement Sales by Type
  8. 4.2.1 Global Short-acting Nicotine Replacement Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Short-acting Nicotine Replacement Sales by Type (2021-2032)
  10. 4.2.3 Global Short-acting Nicotine Replacement Sales Market Share by Type (2021-2032)
  11. 4.3 Global Short-acting Nicotine Replacement Revenue by Type
  12. 4.3.1 Global Short-acting Nicotine Replacement Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Short-acting Nicotine Replacement Revenue by Type (2021-2032)
  14. 4.3.3 Global Short-acting Nicotine Replacement Revenue Market Share by Type (2021-2032)
5 Short-acting Nicotine Replacement Market by Application
  1. 5.1 Short-acting Nicotine Replacement Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Short-acting Nicotine Replacement Sales by Application
  5. 5.2.1 Global Short-acting Nicotine Replacement Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Short-acting Nicotine Replacement Sales by Application (2021-2032)
  7. 5.2.3 Global Short-acting Nicotine Replacement Sales Market Share by Application (2021-2032)
  8. 5.3 Global Short-acting Nicotine Replacement Revenue by Application
  9. 5.3.1 Global Short-acting Nicotine Replacement Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Short-acting Nicotine Replacement Revenue by Application (2021-2032)
  11. 5.3.3 Global Short-acting Nicotine Replacement Revenue Market Share by Application (2021-2032)
6 Global Short-acting Nicotine Replacement Sales by Region
  1. 6.1 Global Short-acting Nicotine Replacement Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Short-acting Nicotine Replacement Sales by Region (2021-2032)
  3. 6.2.1 Global Short-acting Nicotine Replacement Sales by Region (2021-2026)
  4. 6.2.2 Global Short-acting Nicotine Replacement Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Short-acting Nicotine Replacement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Short-acting Nicotine Replacement Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Short-acting Nicotine Replacement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Short-acting Nicotine Replacement Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Short-acting Nicotine Replacement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Short-acting Nicotine Replacement Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Short-acting Nicotine Replacement Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Short-acting Nicotine Replacement Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Short-acting Nicotine Replacement Revenue by Region
  1. 7.1 Global Short-acting Nicotine Replacement Revenue by Region
  2. 7.1.1 Global Short-acting Nicotine Replacement Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Short-acting Nicotine Replacement Revenue by Region (2021-2026)
  4. 7.1.3 Global Short-acting Nicotine Replacement Revenue by Region (2027-2032)
  5. 7.1.4 Global Short-acting Nicotine Replacement Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Short-acting Nicotine Replacement Revenue (2021-2032)
  8. 7.2.2 North America Short-acting Nicotine Replacement Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Short-acting Nicotine Replacement Revenue (2021-2032)
  11. 7.3.2 Europe Short-acting Nicotine Replacement Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Short-acting Nicotine Replacement Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Short-acting Nicotine Replacement Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Short-acting Nicotine Replacement Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Short-acting Nicotine Replacement Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Nicorette (Johnson & Johnson)
  2. 8.1.1 Nicorette (Johnson & Johnson) Company Information
  3. 8.1.2 Nicorette (Johnson & Johnson) Business Overview
  4. 8.1.3 Nicorette (Johnson & Johnson) Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Nicorette (Johnson & Johnson) Short-acting Nicotine Replacement Product Portfolio
  6. 8.1.5 Nicorette (Johnson & Johnson) Recent Developments
  7. 8.2 Nicotinell (Haleon)
  8. 8.2.1 Nicotinell (Haleon) Company Information
  9. 8.2.2 Nicotinell (Haleon) Business Overview
  10. 8.2.3 Nicotinell (Haleon) Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Nicotinell (Haleon) Short-acting Nicotine Replacement Product Portfolio
  12. 8.2.5 Nicotinell (Haleon) Recent Developments
  13. 8.3 Equate (Walmart)
  14. 8.3.1 Equate (Walmart) Company Information
  15. 8.3.2 Equate (Walmart) Business Overview
  16. 8.3.3 Equate (Walmart) Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Equate (Walmart) Short-acting Nicotine Replacement Product Portfolio
  18. 8.3.5 Equate (Walmart) Recent Developments
  19. 8.4 Thrive (Haleon)
  20. 8.4.1 Thrive (Haleon) Company Information
  21. 8.4.2 Thrive (Haleon) Business Overview
  22. 8.4.3 Thrive (Haleon) Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thrive (Haleon) Short-acting Nicotine Replacement Product Portfolio
  24. 8.4.5 Thrive (Haleon) Recent Developments
  25. 8.5 NiQuitin (Perrigo)
  26. 8.5.1 NiQuitin (Perrigo) Company Information
  27. 8.5.2 NiQuitin (Perrigo) Business Overview
  28. 8.5.3 NiQuitin (Perrigo) Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NiQuitin (Perrigo) Short-acting Nicotine Replacement Product Portfolio
  30. 8.5.5 NiQuitin (Perrigo) Recent Developments
  31. 8.6 Philip Morris
  32. 8.6.1 Philip Morris Company Information
  33. 8.6.2 Philip Morris Business Overview
  34. 8.6.3 Philip Morris Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Philip Morris Short-acting Nicotine Replacement Product Portfolio
  36. 8.6.5 Philip Morris Recent Developments
  37. 8.7 Alkalon
  38. 8.7.1 Alkalon Company Information
  39. 8.7.2 Alkalon Business Overview
  40. 8.7.3 Alkalon Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Alkalon Short-acting Nicotine Replacement Product Portfolio
  42. 8.7.5 Alkalon Recent Developments
  43. 8.8 LUCY GOODS
  44. 8.8.1 LUCY GOODS Company Information
  45. 8.8.2 LUCY GOODS Business Overview
  46. 8.8.3 LUCY GOODS Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LUCY GOODS Short-acting Nicotine Replacement Product Portfolio
  48. 8.8.5 LUCY GOODS Recent Developments
  49. 8.9 Dr. Reddy's Laboratories
  50. 8.9.1 Dr. Reddy's Laboratories Company Information
  51. 8.9.2 Dr. Reddy's Laboratories Business Overview
  52. 8.9.3 Dr. Reddy's Laboratories Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dr. Reddy's Laboratories Short-acting Nicotine Replacement Product Portfolio
  54. 8.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 8.10 Nicotex (Cipla Health)
  56. 8.10.1 Nicotex (Cipla Health) Company Information
  57. 8.10.2 Nicotex (Cipla Health) Business Overview
  58. 8.10.3 Nicotex (Cipla Health) Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nicotex (Cipla Health) Short-acting Nicotine Replacement Product Portfolio
  60. 8.10.5 Nicotex (Cipla Health) Recent Developments
  61. 8.11 Swedish Match
  62. 8.11.1 Swedish Match Company Information
  63. 8.11.2 Swedish Match Business Overview
  64. 8.11.3 Swedish Match Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Swedish Match Short-acting Nicotine Replacement Product Portfolio
  66. 8.11.5 Swedish Match Recent Developments
  67. 8.12 Altria
  68. 8.12.1 Altria Company Information
  69. 8.12.2 Altria Business Overview
  70. 8.12.3 Altria Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Altria Short-acting Nicotine Replacement Product Portfolio
  72. 8.12.5 Altria Recent Developments
  73. 8.13 British American Tobacco (BAT)
  74. 8.13.1 British American Tobacco (BAT) Company Information
  75. 8.13.2 British American Tobacco (BAT) Business Overview
  76. 8.13.3 British American Tobacco (BAT) Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 British American Tobacco (BAT) Short-acting Nicotine Replacement Product Portfolio
  78. 8.13.5 British American Tobacco (BAT) Recent Developments
  79. 8.14 Skruf Snus
  80. 8.14.1 Skruf Snus Company Information
  81. 8.14.2 Skruf Snus Business Overview
  82. 8.14.3 Skruf Snus Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Skruf Snus Short-acting Nicotine Replacement Product Portfolio
  84. 8.14.5 Skruf Snus Recent Developments
  85. 8.15 Japan Tobacco International (JTI)
  86. 8.15.1 Japan Tobacco International (JTI) Company Information
  87. 8.15.2 Japan Tobacco International (JTI) Business Overview
  88. 8.15.3 Japan Tobacco International (JTI) Short-acting Nicotine Replacement Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Japan Tobacco International (JTI) Short-acting Nicotine Replacement Product Portfolio
  90. 8.15.5 Japan Tobacco International (JTI) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Short-acting Nicotine Replacement Value Chain Analysis
  2. 9.1.1 Short-acting Nicotine Replacement Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Short-acting Nicotine Replacement Production Mode & Process
  6. 9.2 Short-acting Nicotine Replacement Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Short-acting Nicotine Replacement Distributors
  9. 9.2.3 Short-acting Nicotine Replacement Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst